AtriCure (ATRC) EBITDA Margin (2010 - 2026)
AtriCure's (ATRC) quarterly EBITDA Margin came in at 6.29% in Q2 2026, up 1084.0% year-over-year from 0.53% in Q2 2025, and up 1589.66% quarter-over-quarter from 0.37% in Q1 2026.
Powered by 
Analysis
AtriCure (ATRC) EBITDA Margin (2010 - 2026) Analysis & Trends
AtriCure (ATRC) has reported EBITDA Margin for 17 consecutive years, with 6.29% the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBITDA Margin rose 1084.0% year-over-year to 6.29% in Q2 2026; TTM through Jun 2026 was 2.26%, a 908.0% increase from a year earlier, with the FY2025 full-year figure at 1.77%, up 683.0% from the prior year.
- EBITDA Margin was 6.29% for Q2 2026 at AtriCure, up from 0.37% in the prior quarter.
- Over five years, EBITDA Margin peaked at 6.29% in Q2 2026 and troughed at 18.97% in Q1 2022.
- A 5-year average of 6.36% and a median of 6.17% in 2024 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin tumbled 15292 bps in 2022 and soared 1346 bps in 2025, its largest moves.
- Over 5 years, EBITDA Margin stood at 4.7% in 2022, then slumped by 73 bps to 8.14% in 2023, then slumped by 44 bps to 11.69% in 2024, then soared by 115 bps to 1.77% in 2025, then soared by 255 bps to 6.29% in 2026.
- The last three EBITDA Margin figures came in at 6.29% (Q2 2026), 0.37% (Q1 2026), and 1.77% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 13.44% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 33.60% |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 18.08% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 25.18% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 21.65% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 29.48% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 0.40% |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 24.33% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 19.15% |
| 10 | AtriCure | 2.58 Bn | 2.41 Bn | 118.63 Mn | 6.29% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.29% |
| Mar 31, 2026 | 0.37% |
| Dec 31, 2025 | 1.77% |
| Sep 30, 2025 | 0.15% |
| Jun 30, 2025 | -4.55% |
| Mar 31, 2025 | -4.82% |
| Dec 31, 2024 | -11.69% |
| Sep 30, 2024 | -6.39% |
| Jun 30, 2024 | -6.17% |
| Mar 31, 2024 | -10.03% |
| Dec 31, 2023 | -8.14% |
| Sep 30, 2023 | -8.23% |
| Jun 30, 2023 | -4.11% |
| Mar 31, 2023 | -6.18% |
| Dec 31, 2022 | -4.70% |
| Sep 30, 2022 | -12.88% |
| Jun 30, 2022 | -16.16% |
| Mar 31, 2022 | -18.97% |
| Dec 31, 2021 | -17.08% |
| Sep 30, 2021 | 140.04% |